GUIZHOU CHITIANHUA CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.73 CNY | +2.37% |
|
+2.98% | -34.22% |
| Sales 2022 | 2.52B 347M 28.97B | Sales 2023 | 2.25B 310M 25.84B | Capitalization | 4.45B 615M 51.24B |
|---|---|---|---|---|---|
| Net income 2022 | -367M -50.65M -4.22B | Net income 2023 | -119M -16.42M -1.37B | EV / Sales 2022 | 2.33 x |
| Net Debt 2022 | 741M 102M 8.53B | Net Debt 2023 | 691M 95.31M 7.95B | EV / Sales 2023 | 2.29 x |
| P/E ratio 2022 |
-14
x | P/E ratio 2023 |
-37.4
x | Employees | 1,489 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 63.29% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.37% | ||
| 1 week | +2.98% | ||
| Current month | -16.83% | ||
| 1 month | -14.78% | ||
| 3 months | -27.92% | ||
| 6 months | -35.45% | ||
| Current year | -34.22% |
1 week
1.61
1.75
1 month
1.612.16
Current year
1.442.87
1 year
1.443.03
3 years
1.444.45
5 years
1.444.45
10 years
1.4415.70
| Managers | Title | Age | Since |
|---|---|---|---|
Lin Hong Ding
CEO | Chief Executive Officer | 59 | 01/15/01 |
Yong Ye
DFI | Director of Finance/CFO | 39 | - |
Hong Yan Wu
DFI | Director of Finance/CFO | 45 | 22/21/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pu Wang
BRD | Director/Board Member | 55 | - |
Lin Hong Ding
CEO | Chief Executive Officer | 59 | 01/15/01 |
Min Hong Gao
BRD | Director/Board Member | 53 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 1.73 | +2.37% | 17,157,250 |
| 25/24/25 | 1.69 | +1.81% | 16,615,510 |
| 24/24/24 | 1.66 | +0.61% | 12,250,910 |
| 23/24/23 | 1.65 | +1.85% | 15,249,000 |
| 22/24/22 | 1.62 | -3.57% | 16,205,110 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
Guizhou Chitianhua Co Ltd, formerly Guizhou Salvage Pharmaceutical Co Ltd, is a China-based company mainly engaged in chemical production and pharmaceutical production. The chemical business mainly includes the production and sales of urea, methanol and compound fertilizer. The pharmaceutical manufacturing business mainly includes the production and sales of pharmaceuticals and medical devices. The Company's pharmaceutical products include diabetes drugs, cardiovascular drugs, dermatology drugs, gynecological drugs, digestive system drugs, endocrine drugs, psychotropic drugs, among others. The Company mainly conducts businesses within the domestic market.
Sector
Agricultural Chemicals
Calendar
23/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -34.22% | 404M | |
| +0.63% | 15.02B | |
| -17.37% | 13.81B | |
| +3.13% | 12.19B | |
| -15.34% | 9.72B | |
| -11.77% | 7.35B | |
| -.--% | 7.31B | |
| -5.39% | 6.35B | |
| -5.36% | 4.18B | |
| -28.77% | 2.37B |
- Stock Market
- Equities
- 600227 Stock
